Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part I: Studies of cancer in families

Cancer

Volumn 86, Issue 8 SUPPL., 1999, Pages 1629-1636

  Lynch, Henry T ^a   Watson, Patrice ^a   Shaw, Trudy G ^a   Lynch, Jane F ^a   Harty, Anne E ^a   Franklin, Barbara A ^a   Kapler, Christine R ^a   Tinley, Susan T ^a   Liu, Bo ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cancer genetics; Colorectal carcinoma; Genetic counseling; Genetic testing; Hereditary cancer; Hereditary nonpolyposis colorectal carcinoma

Indexed keywords

CANCER GENETICS; COLORECTAL CANCER; CONFERENCE PAPER; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033569908     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19991015)86:8+<1629::aid-cncr1>3.0.co;2-z     Document Type: Conference Paper

References (17)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Lynch HT, Smyrk TC, Cavalieri J, Lynch JF. Identification of an HNPCC family. Am J Gastroenterol 1994;89: 605-9.
3. Lynch HT, Boman BM, Lanspa SJ, Smyrk T, Lynch JF. Heritage of colonic polyps. In: Herrera L, editor. Familial adenomatous polyposis. New York: Alan R. Liss, Inc., 1990:9-15.
4. Kruse R, Rütten A, Lamberti C, Hosseiny-Malayeri HR, Wang Y, Ruelfs C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998;63:63-70.
5. Lynch HT, Lynch PM, Pester JA, Fusaro RM. Sebaceous neoplasia and visceral cancer (Torre's syndrome) and its relationship to the cancer family syndrome. In: Lynch HT, Fusaro RM, editors. Cancer-associated genodermatoses. New York: Van Nostrand Reinhold, 1982:366-93.
6. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 1985; 113:295-301.
7. Lynch HT, Fusaro RM. Muir-Torre syndrome: heterogeneity, natural history, diagnosis, and management. Probl Gen Surg 1993;10:1-14.
8. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-6.
9. American Society of Clinical Oncology Ad Hoc Task Force on Cancer Genetics Education. Resource document for curriculum development in cancer genetics education. J Clin Oncol 1997;15:2157-69.
10. Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, et al. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 1999;109:91-8.
11. Lynch HT, Severin MJ, Mooney MJ, Lynch JF. Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome. Gynecol Oncol 1995;57: 23-6.
12. Lynch HT, Paulson J, Severin M, Lynch J, Lynch P. Failure to diagnose hereditary colorectal cancer and its medicolegal implications: a hereditary nonpolyposis colorectal cancer case. Dis Colon Rectum 1999;42:31-5.
13. Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA, Jr. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg 1996;31:177-81.
14. Eng C, Ji H. Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters. Am J Hum Genet 1998;62:1020-2.
15. Marcus JN, Page DL, Watson P, Narod SA, Lenoir GM, Lynch HT. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 1997;80(Suppl):543-56.
16. Watson P, Lin K, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members. Cancer 1998;83:259-66.
17. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.